BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 41 minutes ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 37 minutes ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 31 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 40 minutes ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 45 minutes ago Abbott reports positive results from study on its atrial fibrillation therapies 1 hour ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 41 minutes ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 37 minutes ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 31 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 40 minutes ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 45 minutes ago Abbott reports positive results from study on its atrial fibrillation therapies 1 hour ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Market News

Accenture (ACN) beats Q2 revenue and earnings estimates

Accenture (NYSE: ACN) reported revenue and earnings that surpassed market expectations for the second quarter of 2020. The stock was up by 3.2% in premarket hours on Thursday. Revenues increased 7% to $11.14 billion versus the prior-year period. Revenues grew 8% in local currency. The topline results were ahead of forecasts of $11.11 billion. Net […]

$ACN March 19, 2020 2 min read

Accenture (NYSE: ACN) reported revenue and earnings that surpassed market expectations for the second quarter of 2020. The stock was up by 3.2% in premarket hours on Thursday.

Revenues increased 7% to $11.14 billion versus the prior-year period. Revenues grew 8% in local currency. The topline results were ahead of forecasts of $11.11 billion.

Accenture beat Q2 2020 revenue and earnings estimates

Net income attributable to Accenture was $1.23 billion, or
$1.91 per share, compared to $1.12 billion, or $1.73 per share, in the
prior-year period. Analysts had forecast EPS of $1.72.

New bookings were $14.2 billion, with consulting bookings of
$7.2 billion and outsourcing bookings of $7 billion. Consulting revenues
increased 7% while outsourcing revenues grew 6% in the quarter.

Days services outstanding, or DSOs, were 39 days at Feb. 29,
2020, compared with 40 days in the same period a year ago.

ADVERTISEMENT

The company saw revenue increases across all its operating
groups and geographic regions during the quarter, with the exception of Europe
which remained flat compared to the year-ago period.  

Accenture declared a quarterly cash dividend of $0.80 per
share, payable on May 15, 2020, to shareholders of record on April 16, 2020.

For the third quarter of 2020, Accenture expects revenues to be $10.75 billion to $11.15 billion, reflecting a growth of negative 2% to positive 2% in local currency.

The company has lowered its guidance for fiscal year 2020 to reflect the impact of the coronavirus epidemic. Revenue growth is now expected to be in the range of 3-6% in local currency, compared to the previous range of 6-8%. Diluted EPS is now estimated to be $7.48 to $7.70, versus the prior guidance of $7.66 to $7.84.

ADVERTISEMENT